| Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—an emerging role for gut microbiome S MahmoudianDehkordi, M Arnold, K Nho, S Ahmad, W Jia, G Xie, ... Alzheimer's & Dementia 15 (1), 76-92, 2019 | 554 | 2019 |
| Metabolic network failures in Alzheimer's disease: A biochemical road map JB Toledo, M Arnold, G Kastenmüller, R Chang, RA Baillie, X Han, ... Alzheimer's & Dementia 13 (9), 965-984, 2017 | 430 | 2017 |
| Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers K Nho, A Kueider-Paisley, S MahmoudianDehkordi, M Arnold, ... Alzheimer's & Dementia 15 (2), 232-244, 2019 | 268 | 2019 |
| Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers K Nho, A Kueider-Paisley, S Ahmad, S MahmoudianDehkordi, M Arnold, ... JAMA network open 2 (7), e197978-e197978, 2019 | 194 | 2019 |
| Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome M Arnold, K Nho, A Kueider-Paisley, T Massaro, K Huynh, B Brauner, ... Nature Communications 11 (1), 1-12, 2020 | 158 | 2020 |
| Site‐selective functionalization of carbon nanotubes MS Raghuveer, A Kumar, MJ Frederick, GP Louie, PG Ganesan, ... Advanced Materials 18 (5), 547-552, 2006 | 77 | 2006 |
| Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients S Bhattacharyya, AT Ahmed, M Arnold, D Liu, C Luo, H Zhu, ... Translational psychiatry 9 (1), 1-14, 2019 | 72 | 2019 |
| Targeted metabolomics and medication classification data from participants in the ADNI1 cohort L St John-Williams, C Blach, JB Toledo, DM Rotroff, S Kim, K Klavins, ... Scientific data 4, 170140, 2017 | 69 | 2017 |
| Alterations in Acylcarnitines, Amines, and Lipids Inform about Mechanism of Action of Citalopram/Escitalopram in Major Depression S MahmoudianDehkordi, AT Ahmed, S Bhattacharyya, X Han, RA Baillie, ... bioRxiv, 2020 | 64 | 2020 |
| Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort DK Barupal, S Fan, B Wancewicz, T Cajka, M Sa, MR Showalter, R Baillie, ... Scientific data 5, 180263, 2018 | 58 | 2018 |
| Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes AT Ahmed, S MahmoudianDehkordi, S Bhattacharyya, M Arnold, D Liu, ... Journal of Affective Disorders 264, 90-97, 2020 | 45 | 2020 |
| Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment S Bhattacharyya, BW Dunlop, S Mahmoudiandehkordi, AT Ahmed, ... Frontiers in neuroscience 13, 926, 2019 | 20 | 2019 |
| Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts LS John-Williams, S Mahmoudiandehkordi, M Arnold, T Massaro, C Blach, ... Scientific Data 6 (1), 1-8, 2019 | 18 | 2019 |
| Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome (vol 15, pg 76, 2019) S Mahmoudiandehkordi, M Arnold, K Nho, S Ahmad, S Ahmad, W Jia, ... ALZHEIMERS & DEMENTIA 15 (4), 604-604, 2019 | 17 | 2019 |
| Altered Bile Acid Profile Associates with Cognitive Impairment in Alzheimer’s Disease—An Emerging Role for Gut Microbiome. Alzheimers Dement. J. Alzheimers Assoc. 2019, 15 (1 … S MahmoudianDehkordi, M Arnold, K Nho, S Ahmad, W Jia, G Xie, ... | 17* | |
| Identifying differences in bile acid pathways for cholesterol clearance in Alzheimer's disease using metabolic networks of human brain regions. P Baloni, CC Funk, J Yan, JT Yurkovich, A Kueider-Paisley, K Nho, ... bioRxiv, 782987, 2019 | 5 | 2019 |
| The Alzheimer’s Disease Metabolome: Effects of Sex and APOE ε4 genotype M Arnold, K Nho, A Kueider-Paisley, T Massaro, B Brauner, ... bioRxiv, 585455, 2019 | 3 | 2019 |
| Peripheral Serum Metabolomic Profiles Inform Antecedent Central Cognitive Impairment in Older Adults J Wang, R Wei, G Xie, M Arnold, G Louie, S MahmoudianDehkordi, ... bioRxiv, 837989, 2019 | 2 | 2019 |
| METABOLOMIC SIGNATURE OF EXPOSURE AND RESPONSE TO CITALOPRAM/ESCITALOPRAM IN CLINICAL SUBTYPES OF MAJOR DEPRESSION: METABOLOMICS INFORMS ABOUT DISEASE HETEROGENEITY. A Ahmed, S Bhattacharyya, S Mahmoudiandehkordi, D Liu, M Arnold, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 105, S50-S50, 2019 | 1 | 2019 |
| ASSOCIATION OF SERUM-BASED PLASMALOGENS WITH NEUROIMAGING AND GENETIC VARIATION IN ALZHEIMER’S DISEASE K Nho, MA Kling, S MahmoudianDehkordi, M Arnold, DB Goodenowe, ... Alzheimer's & Dementia: The Journal of the Alzheimer's Association 15 (7 …, 2019 | | 2019 |
